Bangor Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
23,737
-52
-0.2% -$2.99K 0.1% 85
2026
Q1
$1.44M Sell
23,789
-787
-3% -$45.9K 0.12% 75
2025
Q4
$1.33M Sell
24,576
-1,414
-5% -$68K 0.11% 86
2025
Q3
$1.17M Sell
25,990
-484
-2% -$22.6K 0.1% 92
2025
Q2
$1.23M Sell
26,474
-380
-1% -$18.7K 0.11% 94
2025
Q1
$1.64M Sell
26,854
-15,191
-36% -$885K 0.15% 71
2024
Q4
$2.38M Sell
42,045
-698
-2% -$39K 0.22% 47
2024
Q3
$2.21M Sell
42,743
-150
-0.3% -$7.04K 0.21% 57
2024
Q2
$1.78M Sell
42,893
-4,697
-10% -$210K 0.18% 73
2024
Q1
$2.58M Sell
47,590
-6,281
-12% -$320K 0.26% 48
2023
Q4
$2.76M Buy
53,871
+1,525
+3% +$80K 0.3% 39
2023
Q3
$3.04M Buy
52,346
+711
+1% +$43.6K 0.36% 33
2023
Q2
$3.3M Buy
51,635
+712
+1% +$47.7K 0.37% 31
2023
Q1
$3.53M Sell
50,923
-1,037
-2% -$73.1K 0.42% 28
2022
Q4
$3.74M Sell
51,960
-9,382
-15% -$707K 0.45% 28
2022
Q3
$4.36M Buy
61,342
+528
+0.9% +$38.3K 0.5% 27
2022
Q2
$4.68M Buy
+60,814
New +$4.63M 0.51% 28
2022
Q1
Sell
-57,667
Closed -$3.6M 194
2021
Q4
$3.6M Buy
57,667
+5,009
+10% +$294K 0.34% 37
2021
Q3
$3.12M Buy
52,658
+6,506
+14% +$428K 0.32% 36
2021
Q2
$3.08M Buy
46,152
+162
+0.4% +$10.6K 0.35% 37
2021
Q1
$2.9M Buy
45,990
+983
+2% +$61.2K 0.35% 38
2020
Q4
$2.79M Buy
45,007
+2,085
+5% +$128K 0.37% 34
2020
Q3
$2.59M Sell
42,922
-1,232
-3% -$74.2K 0.4% 33
2020
Q2
$2.6M Sell
44,154
-388
-0.9% -$23.2K 0.42% 33
2020
Q1
$2.48M Sell
44,542
-1,974
-4% -$121K 0.46% 28
2019
Q4
$2.99M Buy
46,516
+6,526
+16% +$374K 0.47% 27
2019
Q3
$2.03M Sell
39,990
-3,666
-8% -$172K 0.34% 39
2019
Q2
$1.98M Buy
43,656
+14,971
+52% +$697K 0.35% 37
2019
Q1
$1.37M Buy
28,685
+18,009
+169% +$897K 0.26% 62
2018
Q4
$555K Sell
10,676
-1,467
-12% -$78.8K 0.11% 111
2018
Q3
$754K Buy
12,143
+58
+0.5% +$3.44K 0.14% 107
2018
Q2
$668K Sell
12,085
-24
-0.2% -$1.3K 0.13% 109
2018
Q1
$766K Buy
12,109
+659
+6% +$42.4K 0.15% 103
2017
Q4
$702K Buy
11,450
+1,191
+12% +$74.5K 0.14% 103
2017
Q3
$654K Buy
10,259
+1,836
+22% +$107K 0.13% 100
2017
Q2
$470K Buy
8,423
+3,513
+72% +$191K 0.1% 99
2017
Q1
$267K Sell
4,910
-210
-4% -$11.5K 0.06% 127
2016
Q4
$300K Buy
5,120
+335
+7% +$18.3K 0.07% 122
2016
Q3
$258K Buy
4,785
+52
+1% +$3.34K 0.06% 123
2016
Q2
$348K Hold
4,733
0.09% 112
2016
Q1
$303K Sell
4,733
-30
-0.6% -$1.89K 0.08% 117
2015
Q4
$328K Sell
4,763
-15
-0.3% -$991 0.08% 114
2015
Q3
$283K Hold
4,778
0.07% 120
2015
Q2
$318K Sell
4,778
-125
-3% -$8.24K 0.08% 125
2015
Q1
$316K Sell
4,903
-395
-7% -$24.7K 0.08% 126
2014
Q4
$312K Buy
5,298
+400
+8% +$22.6K 0.08% 129
2014
Q3
$251K Sell
4,898
-350
-7% -$17.5K 0.07% 133
2014
Q2
$255K Buy
+5,248
New +$259K 0.07% 131
2014
Q1
Sell
-5,735
Closed -$304K 123
2013
Q4
$304K Sell
5,735
-200
-3% -$10.2K 0.08% 123
2013
Q3
$275K Hold
5,935
0.08% 116
2013
Q2
$265K Buy
+5,935
New +$258K 0.09% 106

Other funds holding BMY

Bangor Savings Bank's BMY Position: Q2 2026 in Review

Bangor Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.22% in Q2 2026, selling an estimated $2.99K and leaving 23,737 shares worth $1.37M. The position accounts for 0.1% of the portfolio, ranked #85.

Bangor Savings Bank first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.68M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bangor Savings Bank held 23,737 shares of Bristol-Myers Squibb worth $1.37M as of Q2 2026.
  • Bangor Savings Bank sold 52 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.99K.
  • Bristol-Myers Squibb made up 0.1% of Bangor Savings Bank's portfolio in Q2 2026, its #85 holding.
  • Bangor Savings Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Bangor Savings Bank's Bristol-Myers Squibb position peaked at $4.68M in Q2 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.